Australia’s leading digital health commercialisation company ANDHealth today announced that Telstra Health has joined its cooperative digital health commercialisation organisation to support the growth of Australia’s digital health industry.

Telstra Health is a leader in delivering digitally enabled care in hospital, pharmacy, and aged and disability care settings. Alongside ANDHealth’s existing core partners, Telstra Health will provide its expertise to digital health companies participating in ANDHealth’s programs, including its Federal Government funded program, ANDHealth+.

ANDHealth’s unique business model which brings together public and private funding with proven expertise from within globally leading digital health organisations has created one of Australia’s most successful technology translation and commercialisation engine rooms. ANDHealth’s programs are recognised nationally and internationally as delivering real and measurable impact with participants in flagship programs creating 417 new jobs (FTEs), impacting more than 600,000 patients, and raising over $87m in financing (dilutive and non-dilutive).

“Telstra Health’s commitment to ANDHealth is a further demonstration of the importance of new technologies to established players in the digital health sector, and the ability of ANDHealth to drive programs which deliver value and measurable outcomes to our partners and to the more than 580 high-growth potential digital health companies we work with,” said ANDHealth CEO, Bronwyn Le Grice.

“Growing our sovereign capability in cutting-edge connected and digital healthcare technology commercialisation is critical to our future health and economic wellbeing. Our partners, including Telstra Health, are critical in delivering our multiplier effect on the number, scale and maturity of our emerging digital health companies across Australia,” said Le Grice.

Telstra Health joins a group of highly committed industry leaders who have partnered with ANDHealth to deliver proven commercialisation outcomes in Australia: Murdoch Children's Research Institute, Novartis Pharmaceuticals, Planet Innovation, Roche Australia, RMIT University, Curve Tomorrow, Beamtree, HPM Executive and Health XL.